Aehr Test Systems Reports Q4 Fiscal 2025 Results: Net Revenue Down to $14.1M, GAAP Net Loss of $2.9M, EPS at $(0.10)

Reuters
07/09
<a href="https://laohu8.com/S/AEHR">Aehr Test Systems</a> Reports Q4 Fiscal 2025 Results: Net Revenue Down to $14.1M, GAAP Net Loss of $2.9M, EPS at $(0.10)

Aehr Test Systems (NASDAQ:AEHR) reported its fiscal 2025 fourth quarter and full year financial results, revealing a decrease in net revenue and a shift from income to loss. For the fourth quarter, net revenue was $14.1 million, down from $16.6 million in the same quarter of the previous year. The company reported a GAAP net loss of $2.9 million, compared to a GAAP net income of $23.9 million, which had included a tax benefit of approximately $20.7 million, in the fourth quarter of fiscal 2024. For the full fiscal year 2025, net revenue totaled $59.0 million, a decline from $66.2 million in fiscal 2024. The GAAP net loss for the year was $3.9 million, contrasting with a GAAP net income of $33.2 million the previous year, which also included a $20.7 million tax benefit. On a non-GAAP basis, which excludes certain adjustments, the company reported a net income of $4.6 million, compared to $35.8 million in fiscal 2024. The company used $7.4 million in cash for operating activities during fiscal 2025. Aehr Test Systems also announced an expansion of its total addressable market and diversification of its customer base, marking a strategic shift in its business operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aehr Test Systems published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1047003) on July 08, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10